Established GICs clearly display mesenchymal traits, greater clonogenic capacity, have greater self-renewal and tumorigenic capability, and express more L1CAM, CD44, CD133 and ITGA6 compared to the non-GIC tumor bulk cells. The gene discussed is L1CAM; the disease is neoplasm.